Redhawk Wealth Advisors
GSK icon

Redhawk Wealth Advisors’s GSK GSK Stock Holding History

Redhawk Wealth Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-29,746
Closed -$1.56M – 423
2026
Q2 		$1.56M Buy
29,746
+1,520
+5% +$80.4K 0.15% 141
2026
Q1 		$1.56M Buy
+28,226
New +$1.53M 0.17% 134
2022
Q3 		– Sell
-3,984
Closed -$217K – 168
2022
Q2 		$217K Buy
3,984
+3
+0.1% +$166 0.1% 153
2022
Q1 		$217K Buy
3,981
+3
+0.1% +$163 0.06% 190
2021
Q4 		$219K Buy
+3,978
New +$207K 0.06% 209
2019
Q3 		– Sell
-254
Closed -$13K – 250
2019
Q2 		$13K Buy
+254
New +$12.7K 0.01% 344

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
JTC Employer Solutions Trustee
JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Equity Investment Corp
Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Redhawk Wealth Advisors's GSK Position: Q3 2026 in Review

Redhawk Wealth Advisors sold out of GSK (GSK) in Q3 2026, closing a stake of 29,746 shares — an estimated $1.56M sold.

Redhawk Wealth Advisors first reported a position in GSK in Q2 2019 and held it in 6 quarters. The position peaked at $1.56M in Q2 2026. 748 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Redhawk Wealth Advisors reported no remaining GSK position as of Q3 2026 after selling out during the quarter.
  • Redhawk Wealth Advisors sold 29,746 GSK shares in Q3 2026, an estimated $1.56M.
  • Redhawk Wealth Advisors first reported a position in GSK in Q2 2019 and held it in 6 quarters.
  • Redhawk Wealth Advisors's GSK position peaked at $1.56M in Q2 2026.
  • 748 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Redhawk Wealth Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.